Studies in Medical Sciences
مجله مطالعات علوم پزشکی
Studies in Medical Sciences
Medical Sciences
http://umj.umsu.ac.ir
37
journal37
2717-008X
2717-008X
10.61186/umj
fa
jalali
1394
5
1
gregorian
2015
8
1
26
5
online
1
fulltext
fa
برآورد سهم چاقی مرکزی بر بار بیماریهای قلبی عروقی در استان آذربایجان غربی
ESTIMATING THE CONTRIBUTION OF CENTRAL OBESITY TO THE BURDEN OF CARDIOVASCULAR DISEASES IN WEST AZERBAIJAN PROVINCE
قلب و عروق
قلب و عروق
پژوهشي(توصیفی- تحلیلی)
Research
<p class="Chekide" dir="rtl" style="text-justify: kashida text-align: justify text-kashida: 0% margin: 0in 0in 0pt unicode-bidi: embed direction: rtl"><b><span lang="AR-SA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt">پیشزمینه و هدف:</span></b><span lang="AR-SA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt"> </span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">بیماریهای قلبی عروقی شایعترین علت مرگومیر در استان آذربایجان غربی میباشد. این</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">مطالعه</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">جهت</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">برآورد</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">سهم</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">عامل</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">خطر</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">تعدیلپذیر چاقی مرکزی</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">و تعیین آثار کاهش شیوع آن بر</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">بار</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">بیماریهای</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">قلبی عروقی انجام</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">گردید</span><span dir="ltr" style="mso-bidi-language: FA"><font size="2"><font face="Times New Roman">.<b> </b></font></font></span></p>
<p> </p>
<p> </p>
<p class="Chekide" dir="rtl" style="text-justify: kashida text-align: justify text-kashida: 0% margin: 0in 0in 0pt unicode-bidi: embed direction: rtl"><b><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">روش</span></b><b><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span></b><b><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">کار:</span></b><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">برای</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">محاسبه</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">سهم</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">عوامل</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">خطر،</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">از</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">روششناسی</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">ارزیابی</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">خطر</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">مقایسهای</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">سازمان</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">جهانی</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">بهداشت</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">استفاده</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">شد. شیوع</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">عامل</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">خطر از <b>دادههای استانی</b> ششمین دور</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">بررسی</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">مراقبت</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">عوامل</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">خطر</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">بیماریهای</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">غیرواگیر سال 90</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">و</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">اندازه</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">اثر</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">مربوطه از</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">مطالعه</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">قند و</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">لیپید</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">تهران</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">استخراج</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">گردید</span><span dir="ltr" style="mso-bidi-language: FA"><font face="Times New Roman" size="2">.</font></span><b><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA"> </span></b></p>
<p> </p>
<p> </p>
<p class="Chekide" dir="rtl" style="text-justify: kashida text-align: justify text-kashida: 0% margin: 0in 0in 0pt unicode-bidi: embed direction: rtl"><b><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">یافتهها: </span></b><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">با کاهش درصد زنان مبتلا به چاقی مرکزی از 19.1 درصد به سطح حداقل خطر تئوریک (صفر) و امکانپذیر (12 درصد)، به ترتیب 9.5 درصد و 3.5 درصد از دالی</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">منتسب به بیماریهای قلبی عروقی قابلاجتناب خواهد بود. در مردان نیز با کاهش شیوع چاقی مرکزی از 18 درصد به سطح خطر تئوریک (صفر) و حداقل خطر امکانپذیر (12 درصد) مقادیر متناظر به ترتیب برابر با 7.4 درصد و 2.5 درصد خواهد بود. </span></p>
<p> </p>
<p> </p>
<p class="Chekide" dir="rtl" style="text-justify: kashida text-align: justify text-kashida: 0% margin: 0in 0in 0pt unicode-bidi: embed direction: rtl"><b><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">نتیجهگیری: </span></b><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">با توجه به سهم قابلتوجه چاقی مرکزی در بار منتسب به بیماریهای قلبی عروقی در استان آذربایجان غربی و در نظر گرفتن این موضوع که چاقی مرکزی در</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">افزایش فشارخون،</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">کلسترول،</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">تری</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">گلیسیرید</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">و قند</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">خون که بهعنوان عوامل خطر بیماریهای قلبی عروقی مطرح هستند</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">نقش</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">مهمی</span><span dir="ltr" lang="FA" style="mso-bidi-language: FA"><font face="Times New Roman" size="2"> </font></span><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA">دارد، پیشگیری و کنترل چاقی مرکزی یک رویکرد اساسی در کاهش ابتلا و میرایی بیماریهای قلبی عروقی خواهد بود. </span></p>
<p> </p>
<p> </p>
<p class="Chekide" dir="rtl" style="text-justify: kashida text-align: justify text-kashida: 0% margin: 0in 0in 0pt unicode-bidi: embed direction: rtl"> </p>
<p class="Chekide" dir="rtl" style="text-justify: kashida text-align: justify text-kashida: 0% margin: 0in 0in 0pt unicode-bidi: embed direction: rtl"> </p>
<p><span lang="FA" style="font-family: Nazanin font-size: 9.5pt mso-ansi-font-size: 8.5pt mso-bidi-language: FA"> </span></p>
<p> </p>
<p> </p>
<p> <i> <strong>Background & Aims</strong> </i><strong>: </strong>Cardiovascular diseases are the most common cause of death in West Azerbaijan province. This study was conducted to estimate the contribution to the burden of modification risk factor of central obesity and determine the effect of reducing its prevalence on cardiovascular diseases in this province.</p>
<p> <strong><i> Materials & Methods </i></strong><strong>: </strong>To calculate the P otential Impact Fraction (PIF) , the World Health Organization comparative risk assessment (CRA) methodology was used. The prevalence of risk factor was obtained from provincial data of the sixth steps survey of non-communicable risk factors which was conducted in 2011 and the effect size of risk factor was extracted from Tehran Lipid and Glucose Study.</p>
<p> <strong><i> Results </i></strong><strong>: </strong>By reducing the percent of women with central obesity from %19.1 to the theoretical (zero level) and the feasible minimum risk level i.e. % 12, respectively 9.5% and 3.5% of attributable Disability Adjusted Life Years (DALYs) to cardiovascular disease were avoidable, also with the decrease in the prevalence of obesity in men from 18 % to the theoretical risk ( zero) and feasible minimum risk ( 12%) the corresponding value were 7.4% and 2.5%, respectively.</p>
<p> <strong><i> Conclusion </i></strong><strong>: </strong>According to the considerable contribution of central obesity on attributable burden of cardiovascular disease in West Azerbaijan province and considering this fact that central obesity has important role in increasing hypertension, cholesterol, triglycerides and blood sugar, prevention and control of central obesity will be an essential approach to reducing morbidity and mortality from cardiovascular diseases.</p>
<p> SOURCE: URMIA MED J 2015: 26(5): 379 ISSN: 1027-3727</p>
بیماریهای قلبی عروقی, بار منتسب, چاقی مرکزی, سهم تأثیر بالقوه
Cardiovascular diseases, Attributable burden, Central obesity, Potential impact fraction
370
379
http://umj.umsu.ac.ir/browse.php?a_code=A-10-4-2&slc_lang=fa&sid=1
Mohsen
Jalilzadeh
محسن
جلیلزاده
3700319475328460012764
3700319475328460012764
No
Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
دانشکده پزشکی، دانشگاه علوم پزشکی ارومیه، ارومیه، ایران
Kamal
Khademvatan
کمال
خادم وطن
3700319475328460012765
3700319475328460012765
No
, Seyed Al-Shohada Hospital, Urmia University of Medical Sciences, Urmia, Iran
بیمارستان سید الشهدا، دانشگاه علوم پزشکی ارومیه، ارومیه، ایران
Hamid Reza
Khalkhali
حمیدرضا
خلخالی
3700319475328460012766
3700319475328460012766
No
Department of Epidemiology and Biostatistics, Faculty of Public Health, Urmia University
گروه اپیدمیولوژی و آمارزیستی، دانشکده پزشکی ارومیه، دانشگاه علوم پزشکی ارومیه، ارومیه، ایران
Shaker
Salarilak
شاکر
سالاری لک
salari@iaut.ac.ir, salarilak@yahoo.com
3700319475328460012767
3700319475328460012767
Yes
Department of Public Health, Medical Sciences Faculty, Tabriz Branch, Islamic Azad University, Tabriz, Iran
گروه بهداشت عمومی، دانشکده علوم پزشکی، واحد تبریز، دانشگاه آزاد اسلامی، تبریز، ایران